Saturday, January 28, 2023

2023-01-24 | OTCPK:MJNA | Press Release | Medical Marijuana Inc - Stockhouse

New Products Offer 3,000mg to 6,000mg, Will Come in Jars of 30 and 60mL, Presenting Significant Cost Savings to Rapidly Growing Brazil Market

SAN DIEGO, CA, Jan. 24, 2023 (GLOBE NEWSWIRE) -- via NewMediaWireMedical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that its subsidiary HempMeds Brasil launched two new full spectrum products in Brazil. The two products represent the most competitively priced products available in the region, creating greater market opportunity for the subsidiary.

HempMeds Brasil and Medical Marijuana, Inc. were the first companies to receive historic, first-ever permits to import hemp-based cannabidiol (CBD) oil after a Brazilian family successfully sued the equivalent of Brazil’s FDA, the Brazilian Health Surveillance Industry (ANVISA), for the right to access CBD oil for a child with CDKL5 epilepsy. Since then HempMeds Brasil has experienced consistent growth in reaching new patients through its relationships with various medical associations as well as its direct-to-consumer business. CBD products sold in Brazil require a prescription from a doctor and once obtained HempMeds Brazil assists Patients to obtain the prescribed product. The Company has long been in the process to garner the necessary approvals to distribute its products through pharmacies as...

source: https://news.google.com/__i/rss/rd/articles/CBMigAFodHRwczovL3N0b2NraG91c2UuY29tL25ld3MvcHJlc3MtcmVsZWFzZXMvMjAyMy8wMS8yNC9tZWRpY2FsLW1hcmlqdWFuYS1pbmMtc3Vic2lkaWFyeS1oZW1wbWVkcy14YWUtYnJhc2lsLWxhdW5jaGVzLXR3by1uZXctZnVsbNIBAA?oc=5